Abdulkareem Sultan Al Olama – CEO, Al Jalila Foundation, UAE

18.02.2020
Dr Abdulkareem Sultan Al Olama, CEO of the Al Jalila Foundation, discusses the Foundation’s goal to position the UAE at the forefront of medical education and research, the importance of top-level international partnerships, as well as the Foundation’s exciting upcoming projects to propel the UAE as a hub for the fourth industrial revolution.  
The Al Jalila Foundation focuses on the biggest health challenges in the region: cardiovascular diseases, obesity, diabetes, cancer and mental health problems
Become a PharmaBoardroom Member for free to access this content
Join the 20,000+ pharmaceutical professionals who already subscribe to PharmaBoardroom
Register
Already a member? Sign In
Tags:
UAE, Foundation, Al Jalila Foundation, Medical Education

Related Interviews

Tarek El Rahbani – Managing Director MENA, Boston Scientific

Working non-stop to catch up with its footprint in other regions, Boston Scientific is investing heavily in the MENA markets. Tarek El Rahbani, managing director for the region, shares the…

Ronald Boueri – General Manager, Zimmer Biomet Middle East

Ronald Boueri of Zimmer Biomet Middle East discusses the challenges of establishing the business, the importance of providing the latest innovation and assistance to medical professionals in the MENA (Middle…

Abbas Virji & Shalina Clifford – Co-CEOs, Shalina Healthcare, UAE

Sub-Saharan Africa might not be considered among the top destinations for the global pharmaceutical industry, but Shalina Healthcare considers it home and has established itself as the leading pharma company…

Related Articles

MEA / 3 Regional Pharma Managers on their Middle East Go-To-Market Strategies

The Middle East and Africa (MEA) region is vast and is predominantly composed of emerging countries with varying levels of income and healthcare infrastructure. Here, three regional managers for pharma…

MEA / The Pharma Commercialisation Model of the Future

Amgen MEA’s Mohamed Nasser* examines the current pharma commercialisation model, posits how the entire healthcare ecosystem’s rapid and effective response to COVID-19 could be replicable in other disease areas, and…

MENA / Egypt Opens 'Pharma City'; Koçak’s COVID Vaccine Enters Phase I; Abu Dhabi Strengthens Hub Status

The latest Middle East and North Africa (MENA) pharma, including Egypt’s opening of the largest “pharmaceutical city” in the Middle East and Abu Dhabi’s quest to become a pharma hub…

Latest Report

Singapore Pharma Report 2021

Related Content

UAE
Foundation
Al Jalila Foundation
Medical Education